The abstract is read at the publisher; the summary is JClub's.
In an ouabain-induced auditory neuropathy model, MITF directly upregulates SCD1 to suppress ferroptosis and preserve spiral ganglion neuron survival and hearing function.
- Why it matters: Spiral ganglion neuron degeneration drives irreversible sensorineural hearing loss, but the ferroptosis-linked mechanisms and actionable molecular targets are not well defined.
- What they did: The study used transcriptomics, lipidomics, functional ferroptosis assays, and pharmacologic ferroptosis inhibition in SGNs, then tested SCD1 and MITF by overexpression, supplementation, and genetic disruption, including a cisplatin ototoxicity model.
- The result: Restoring SCD1 activity via SCD1 overexpression or monounsaturated fatty acid supplementation mitigated ouabain- and cisplatin-associated ferroptosis and hearing impairment, while SCD1 or MITF disruption abrogated protection.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.